Lucas Franki is an associate editor for MDedge News, and has been with the company since 2014. He has a BA in English from Penn State University and is an Eagle Scout.
News
Clinical Trial: The Checklist to Prevent MRSA Surgical Site Infections
The VA has developed a new checklist which will be tested in hopes of reducing MRSA surgical site infections.
News
Denosumab indication now includes multiple myeloma, Amgen announces
Denosumab, which is not cleared through the kidneys, offers multiple myeloma patients bone protection with a convenient subcutaneous...
News
Thrombectomy shines in presence of a clinical deficit and imaging mismatch
Less disability, greater functional independence, and less neurologic deterioration was observed for thrombectomy plus standard care.
News
U.S. autism rates edge up from 2014-2016
Increase in ASD prevalence rates are not statistically significant, epidemiologists report.
News
Pertuzumab approved for HER2-positive breast cancer
After a median follow-up period of 45.4 months, an invasive disease event occurred in 7.1% of all patients who received pertuzumab (Perjeta) and...
News
FDA expands approval of nivolumab for melanoma treatment
Nivolumab was approved for the adjuvant treatment of melanoma patients with involvement of lymph nodes or in patients with metastatic disease who...
News
FDA approves Eskata for treatment of raised SKs
Topical solution should be used only in the office of a health care provider, not in the home.
News
FDA approves infliximab biosimilar Ixifi for all of Remicade’s indications
It is the third biosimilar of Remicade to be approved by the FDA.
News
Clinical trial: The Role of the Robotic Platform in Inguinal Hernia Repair Surgery
An interventional trial to examine robotic platform efficacy is currently recruiting patients who require inguinal hernia repair surgery.
News
PBC disease progression no worse for patients with concomitant NAFLD
Immune recruitment into the liver in NAFLD may explain the discrepancy.
News
FDA: Puerto Rico’s medical supply shortage issues continue
Intravenous saline products and amino acids for injection are both in short supply.
News
FDA: Febuxostat may have increased heart-related death risk
The agency reported preliminary findings from a postmarketing safety study started after febuxostat’s approval in 2009.
News
FDA approves obinutuzumab for follicular lymphoma
Approval is based on a 28% lower risk of disease progression or death after 2 years for patients on the obinutuzumab-based regimen.
News
Infliximab useful in a case of concurrent RA/PBC
The anti–tumor necrosis factor alpha agent appears to be safe and effective for both diseases, especially when the rheumatoid arthritis flared.
News
FDA approves Vimpat for POS treatment in children with epilepsy
The drug has previously been approved for use in adults.